TCTR20180920008招募中2 期
A Comparative study of the conservative treatment versus multiple drilling and conventional surgical methods in the management of avascular necrosis of femoral head
Faculty of Medicine,Tabriz university Of Medical sciences,Tabriz,Iran.0 个研究点目标入组 104 人开始时间: 2018年9月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •all patients with ONFH
排除标准
- •exclusion criteria was patients with ONFH caused by trauma and Ficat stage of III and IV
研究者
相似试验
已完成
1 期
Treatment of Tennis Elbowateral Epicondylitis.Lateral epicondylitisIRCT2015110224596N2Vice Chancellor for Research of the Hamadan University of Medical Sciences30
已完成
3 期
Study of four conservative treatment of osteoarthritisOsteoarthritis.IRCT20190114042360N1Hamedan University of Medical Sciences120
招募中
4 期
Evaluation of two different conservative treatment concepts for non-dislocated radial head fracturesDRKS00024018Evangelisches Krankenhaus Oldenburg40
招募中
Unknown
Investigation and comparison of two treatment protocols based on transcranial direct current stimulation (Tdcs) and treatment based on acceptance and commitment (ACT) on reducing the intensity of pain, anxiety and depression in patients with rheumatoid arthritis.rheumatoid arthritis.IRCT20240629062274N1Khoram-Abad University of Medical Sciences60
进行中（未招募）
1 期
A randomized study comparing maintenance therapy withsubcutaneous rituximab continued until progression with observation only in patients with relapsed or refractory, indolent non-Hodgkin’s lymphoma who completed and responded to rituximab-based immunochemotherapy induction and initial 2-year rituximab maintenance therapy administered subcutaneously.Patients with relapsed or refractory CD20+ follicular non-Hodgkin's lymphoma (NHL) Grade 1, 2 or 3a, or other CD20+ indolent NHL (Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma, marginal zone lymphoma), according to the WHO classification system, or other not further classified low malignant lymphoma by immunohistochemistry.MedDRA version: 14.1Level: PTClassification code 10061170Term: Follicle centre lymphoma, follicular grade I, II, IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023407-95-ITROCHE692